Hashimoto’s pathophysiology
- Autoantibody and T cell mechanisms: Anti-TPO and anti-thyroglobulin antibodies are present in 90% and 70% of Hashimoto’s patients respectively. Intrathyroidal CD4+ and CD8+ T cell infiltration drives follicular destruction via apoptosis (Fas-FasL) and cytotoxicity. NK cells participate in follicular cell destruction — this is the basis for the NK stimulation concern in autoimmune thyroiditis, though the overall magnitude of this concern is lower than in conditions requiring systemic immunosuppression.
- Thyrocyte NOX2 and H2O2: Thyroid follicular cells express DUOX1 and DUOX2 (dual oxidase, closely related to NOX family) to generate H2O2for the TPO-catalysed iodide oxidation step in thyroid hormone synthesis. In Hashimoto’s, inflammatory cytokines (IFN-γ, TNF-α) upregulate DUOX expression excessively, generating supraphysiological H2O2that damages thyrocyte DNA and proteins. Phycocyanobilin’s NOX family inhibition may reduce this excess oxidative burden.
- Selenium and thyroid protection: Thyroid tissue has the highest selenium concentration of any tissue in the body. Selenoproteins — glutathione peroxidase (GPx1, GPx4), thioredoxin reductase (TrxR1), and selenoprotein P — are the primary H2O2scavenging defences in thyrocytes. Selenium deficiency worsens Hashimoto’s by reducing GPx capacity. Clinical trials of selenium supplementation (200 µg/day selenomethionine) reduce TPO antibody titres in Hashimoto’s patients. Spirulina contains 10–30 µg selenium per 5 g — a modest but relevant contribution.
Iodine: not a concern with spirulina
- The most common question about spirulina in Hashimoto’s is iodine content. Spirulina contains low iodine (approximately 16–50 µg/100 g, or 0.8–2.5 µg/5 g). The recommended daily intake is 150 µg. Spirulina provides less than 2% of the daily recommended intake per 5 g dose. This is not a clinically relevant iodine load in Hashimoto’s.
- Contrast with true iodine excess risk in Hashimoto’s: high iodine intake (>500 µg/day from seaweed, iodine supplements, or contrast media) can trigger hypothyroid exacerbation via the Wolff-Chaikoff effect. Spirulina does not reach this threshold.
Levothyroxine timing: the critical interaction
- Levothyroxine (T4) absorption is impaired by calcium, magnesium, iron, and dietary fibre — all present in spirulina. These minerals and fibre bind levothyroxine in the GI tract, reducing absorption. The interaction is not pharmacokinetic but pharmacodynamic (absorption competition).
- Rule: Take levothyroxine on an empty stomach 30–60 minutes before breakfast, with only water. Take spirulina with breakfast or later in the day — at least 4 hours after levothyroxine to avoid absorption competition. This is the same rule that applies to calcium supplements, iron supplements, and high-fibre foods on levothyroxine.
- TSH monitoring: if starting or changing spirulina dose while on levothyroxine, check TSH 6–8 weeks later to confirm stability. Even consistent timing separation warrants a TSH check at initiation.
NK stimulation concern in Hashimoto’s
- Hashimoto’s (euthyroid, on levothyroxine replacement only) does not require systemic immunosuppression. No biologics, no rituximab, no mycophenolate. The NK stimulation concern from spirulina is significantly lower than in conditions requiring immunosuppression.
- In practice, spirulina is used by large numbers of Hashimoto’s patients without documented exacerbation. Inform your endocrinologist as a routine supplement disclosure.
- If TPO antibody titres are being monitored: recheck 3–6 months after starting spirulina to confirm no antibody titre increase. This is precautionary rather than based on specific evidence of harm.
Practical guidance
- Levothyroxine timing is the primary practical consideration: 30–60 minutes before breakfast with water only; spirulina with breakfast or later — never simultaneously
- TSH check 6–8 weeks after starting spirulina if on levothyroxine
- 3–5 g/day; selenium content supports thyrocyte GPx antioxidant defence; phycocyanobilin may reduce DUOX2 excess oxidative burden
- Iodine content is not a concern at 5 g/day (0.8–2.5 µg total); does not approach Wolff-Chaikoff threshold
- NK stimulation concern is low in euthyroid Hashimoto’s without immunosuppression; inform endocrinologist as routine disclosure